|
Rachiotek (Formerly Applied Spine Technologies) |
|
|
30, Cold Spring Road
Rocky Hill, CT 06067 USA
phone:203-503-0280
fax:203-503-0282
|
|
| Symbol |
private |
| Founded |
2004 |
| Employees |
15 |
|
|
| www.appliedspine.com
|
|
| Research Sector |
Medical Devices & Tech |
|
 |
| Summary Description |
| Treatment of chronic low back pain. |
|
| Management |
| Craig Corrance, President & Chief Executive Officer; Terry Brennan, Chief Financial Officer; Michele Lucey, Vice President, Regulatory & Quality; Bruce Robie, PhD, Vice President, Research & Development; Manohar Panjabi PhD, Scientific Founder |
| |
|
|
| |
|
| Keywords |
| non-fusion, platform utilizing, patented, dual-spring, mechanism |
|
|
|
| Description |
|
Applied Spine Technologies (AST) develops the Stabilimax NZ to treat chronic lower back pain. |
|
| Products / Services |
Stabilimax NZ is a posterior Flexible Stabilization system designed to support an injured or degenerated spine while preserving spine motion and flexibility
|
|
| Technology / Differentiation |
| Requiring no tissue removal or replacement, the Stabilimax NZ device is a substantially less invasive option for many of the patients who are currently offered fusion or disc replacement. |
|
| Market / Customers |
Of the 30 million patients who report back pain annually in the U.S., over 4.5 million fail conservative treatment and approximately 500,000 of them undergo surgery of the lumbar spine. Currently, worldwide revenues of spine implant devices, virtually all of which are for fusion, are estimated to exceed $2.2 billion.
|
|
| Funding |
| Operations began in February 2004 upon funding from Oxford Bioscience Partners and BioVentures Investors. Subsequent funding has been received from InterWest, DeNovo, Investor Growth Capital, and MB Ventures |
|
|
|
|
|
|
|
Biotech & Specialty Pharma
Healthcare Services
Medical Devices & Tech
OneMedPlace Member
AdvaMed Members